TOMI’s SteraMist Highlighted as Hantavirus Outbreak Fuels Demand for Biohazard Disinfection
Event summary
- TOMI Environmental Solutions emphasizes SteraMist iHP technology’s efficacy against hantavirus amid a rare outbreak on an Atlantic cruise ship, with six cases and three fatalities reported as of May 6, 2026.
- SteraMist’s ionized Hydrogen Peroxide (iHP) technology targets enveloped viruses like hantavirus, which have a fragile outer lipid membrane susceptible to oxidative destruction.
- Dr. Halden Shane, CEO of TOMI, highlights the need for rapid, non-corrosive decontamination to prevent infection outbreaks during cleaning processes.
- TOMI’s technology is positioned as a preferred choice for biohazard remediation in high-risk environments, including hospitals, cruise ships, and commercial structures.
The big picture
TOMI’s push for SteraMist comes as urban sprawl and climate shifts increase human-wildlife interactions, driving demand for validated decontamination technologies. The company’s positioning in biohazard remediation aligns with broader trends in infection prevention, particularly in sectors like healthcare and hospitality where rapid re-entry is critical. TOMI’s technology, originally developed under a DARPA grant, underscores the growing intersection of defense innovation and public health solutions.
What we're watching
- Market Demand
- Whether the rising incidence of zoonotic diseases will sustain long-term demand for TOMI’s specialized decontamination solutions.
- Technological Advantage
- How SteraMist’s rapid-deployment capabilities will differentiate it from traditional cleaning methods in high-stakes environments.
- Regulatory Compliance
- The pace at which global health authorities may mandate advanced disinfection protocols in response to emerging biohazards.
Related topics